Stem Cells vs. Parkinson’s: The Battle of the Century
Welcome! We’re delighted to have you join us on this exploration into a topic that is at the forefront of medical research: the potential of stem cell treatments for Parkinson’s disease. You might be asking, “What exactly is Parkinson’s disease?” It’s a crucial question and one that we need to address before we delve deeper […]
Groundbreaking Trials Aim to Combat Parkinson’s with Patients’ Own Cells
San Diego-based startup Aspen Neuroscience plans to test the potential of lab-cultured brain cells, derived from a person’s own cells, to reverse Parkinson’s disease symptoms in human trials later this year. The company aims to determine if these injected cells can develop into dopamine-producing neurons, alleviating the disease’s debilitating symptoms. Animal tests have shown promise […]
Unlocking the Potential of Stem Cell Therapy in Treating Parkinson’s Disease
Stem cell therapy is an emerging and promising treatment method that has been linked to various diseases, such as Parkinson’s Disease. Stem cells are unique in their ability to develop into specialized cells, tissues, and organs, which allows them to replace cells that have been damaged or lost due to disease. In the context of […]
Exploring Stem Cell Therapy for Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects millions of people around the world. While there currently is no cure, advances in stem cell research have offered new hope for those living with this chronic condition. In this blog post, we will delve into the potential benefits and risks associated with stem cell treatments […]
Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank
SAN DIEGO, Dec. 21, 2022 /PRNewswire/ — Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies including the first iPSC-derived autologous neuron replacement treatment for Parkinson’s disease (PD), has signed a $40 million credit facility with Silicon Valley Bank (SVB). Deal terms were not disclosed. “We are pleased to work with Silicon Valley Bank. As a leader […]
Parkinson’s & Stem Cell Therapy Research
Stem cells are the body’s building blocks, capable of multiplying itself and creating other differentiated cells. Every day, scientists are learning more and more about their potential, and the use of these cells as an internal repair system. From laboratory test tubes to human trials, stem cells are giving new hope to a myriad of […]
NeuriTest™ Presented Publicly for the First Time at the International Society for Stem Cell Research Annual Meeting
SAN DIEGO, June 22, 2022 /PRNewswire/ — Aspen Neuroscience, Inc. Director of Bioinformatics, Roy Williams, Ph.D., presented NeuriTest™ for the first time publicly last week at the 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting in San Francisco, Calif. Dr. Williams’ podium presentation, “NeuriTest: A Bioinformatics-based Tool for Quality Control of iPSC-derived Dopamine Neuron Precursors […]
Seelos Therapeutics Announces Data Demonstrating Statistically Significant Downregulation of mRNA and Reduction of Alpha Synuclein in an In Vitro Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 in Dementia with Lewy Bodies
NEW YORK, June 9, 2022 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced data demonstrating a statistically significant (p<0.01) 19% downregulation of mRNA and a ~40% reduction of alpha synuclein (α-synuclein) in an in vitro study […]
Stem cells helping patients with Parkinson’s Disease
News segment from Houston’s KPRC talking about the first FDA approved stem cell trial that is happening to help patient’s dealing with Parkinson’s Disease. Video Transcript: More than 10 million people worldwide are living with Parkinson’s and 60,000 are in the U.S.. It’s a chronic progressive disease, which means it gets worse over time. But […]
FUJIFILM Cellular Dynamics Launches Parkinson’s Disease iCell DopaNeurons featuring LRRK2 and GBA Mutations
MADISON, Wis., May 24, 2022 (GLOBE NEWSWIRE) — FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) products, announced today the launch of Parkinson’s disease (PD) iCell DopaNeurons featuring LRRK2 (G2019S) and GBA (N370S) mutations, which are common PD risk-associated mutations. These PD iCell DopaNeurons were developed […]